A Study to Assess the Molecular Differences in Primary Malignant Melanoma and Healthy Tissue

Overview

About this study

The purpose of this study is to learn more about the cause of the different patterns and colors seen in melanomas, with the hope of better understanding genes expressed in melanomas. The value is that the findings may alter the approach to patients with more locally advanced melanomas.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

Clinically diagnosed primary MM with distinct dermoscopic features, suitable for excision, and at least 1.2 x 1.0 cm size

Exclusion Criteria:

Unable to obtain tissue excision with local anesthesia, histology not compatible with melanoma, lesion size smaller than 1.2 x 1.0 cm

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status
Scottsdale/Phoenix, Ariz. Mayo Clinic principal investigator David Swanson, M.D.	Closed for enrollment

Mayo Clinic Location

Status

Scottsdale/Phoenix, Ariz.

Mayo Clinic principal investigator

David Swanson, M.D.

Closed for enrollment

More information

Publications

Publications are currently not available

Clinical Trials